|
1.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
International Collaboration of
Epidemiological Studies of Cervical Cancer: Comparison of risk
factors for invasive squamous cell carcinoma and adenocarcinoma of
the cervix: collaborative reanalysis of individual data on 8,097
women with squamous cell carcinoma and 1,374 women with
adenocarcinoma from 12 epidemiological studies. Int J Cancer.
120:885–891. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: a meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Castellsagué X, Díaz M, de Sanjosé S,
Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS,
Snijders PJ, Meijer CJ and Bosch FX; International Agency for
Research on Cancer Multicenter Cervical Cancer Study Group:
Worldwide human papillomavirus etiology of cervical adenocarcinoma
and its cofactors: implications for screening and prevention. J
Natl Cancer Inst. 98:303–315. 2006.PubMed/NCBI
|
|
5.
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Andersson S, Rylander E, Larsson B, Strand
A, Silfversvärd C and Wilander E: The role of human papillomavirus
in cervical adenocarcinoma carcinogenesis. Eur J Cancer.
37:246–250. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Gustafsson L, Pontén J, Zack M and Adami
HO: International incidence rates of invasive cervical cancer after
introduction of cytological screening. Cancer Causes Control.
8:755–763. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Vizcaino AP, Moreno V, Bosch FX, Muñoz N,
Barros-Dios XM, Borras J and Parkin DM: International trends in
incidence of cervical cancer: II. Squamous-cell carcinoma. Int J
Cancer. 86:429–435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Visioli CB, Zappa M, Ciatto S, Iossa A and
Crocetti E: Increasing trends of cervical adenocarcinoma incidence
in Central Italy despite Extensive Screening Program, 1985–2000.
Cancer Detect Prev. 28:461–464. 2004.PubMed/NCBI
|
|
10.
|
Bray F, Carstensen B, Møller H, Zappa M,
Zakelj MP, Lawrence G, Hakama M and Weiderpass E: Incidence trends
of adenocarcinoma of the cervix in 13 European countries. Cancer
Epidemiol Biomarkers Prev. 14:2191–2199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Etherington IJ and Luesley DM:
Adenocarcinoma in situ of the cervix - controversies in diagnosis
and treatment. J Low Genit Tract Dis. 5:94–98. 2001.PubMed/NCBI
|
|
12.
|
Jaworski RC: Endocervical glandular
dysplasia, adenocarcinoma in situ, and early invasive
(microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn
Pathol. 7:190–204. 1990.PubMed/NCBI
|
|
13.
|
Andrae B, Kemetli L, Sparén P, Silfverdal
L, Strander B, Ryd W, Dillner J and Törnberg S:
Screening-preventable cervical cancer risks: evidence from a
nationwide audit in Sweden. J Natl Cancer Inst. 100:622–629. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wright TC Jr, Schiffman M, Solomon D, Cox
JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C and
Saslow D: Interim guidance for the use of human papillomavirus DNA
testing as an adjunct to cervical cytology for screening. Obstet
Gynecol. 103:304–309. 2004. View Article : Google Scholar
|
|
15.
|
Cuschieri KS and Cubie HA: The role of
human papillomavirus testing in cervical screening. J Clin Virol.
32(Suppl 1): S34–S42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Meijer CJ, Berkhof J, Castle PE, Hesselink
AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J,
Heideman DA and Snijders PJ: Guidelines for human papillomavirus
DNA test requirements for primary cervical cancer screening in
women 30 years and older. Int J Cancer. 124:516–520.
2009.PubMed/NCBI
|
|
17.
|
Dillner J, Rebolj M, Birembaut P, Petry
KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer
S, Cuzick J, van Ballegooijen M, Clavel C and Iftner T; Joint
European Cohort Study: Long term predictive values of cytology and
human papillomavirus testing in cervical cancer screening: joint
European cohort study. BMJ. 337:a17542008. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Dahlström LA, Ylitalo N, Sundström K,
Palmgren J, Ploner A, Eloranta S, Sanjeevi CB, Andersson S, Rohan
T, Dillner J, Adami HO and Sparén P: Prospective study of human
papillomavirus and risk of cervical adenocarcinoma. Int J Cancer.
127:1923–1930. 2010.PubMed/NCBI
|
|
19.
|
Gyllensten U, Gustavsson I, Lindell M and
Wilander E: Primary high-risk HPV screening for cervical cancer in
post-menopausal women. Gynecol Oncol. 125:343–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Sanner K, Wikström I, Strand A, Lindell M
and Wilander E: Self-sampling of the vaginal fluid at home combined
with high-risk HPV testing. Br J Cancer. 101:871–874. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Richart RM: Cervical intraepithelial
neoplasia. Pathol Annu. 8:301–328. 1973.PubMed/NCBI
|
|
22.
|
Solomon D, Davey D, Kurman R, Moriarty A,
O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr and
Young N; Forum Group Members; Bethesda 2001 Workshop: The 2001
Bethesda System: terminology for reporting results of cervical
cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Gustavsson I, Juko-Pecirep I, Backlund I,
Wilander E and Gyllensten U: Comparison between the Hybrid Capture
2 and the hpVIR real-time PCR for detection of human papillomavirus
in women with ASCUS or low grade dysplasia. J Clin Virol. 45:85–89.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Gustavsson I, Lindell M, Wilander E,
Strand A and Gyllensten U: Use of FTA card for dry collection,
transportation and storage of cervical cell specimen to detect
high-risk HPV. J Clin Virol. 46:112–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Moberg M, Gustavsson I and Gyllensten U:
Real-time PCR-based system for simultaneous quantification of human
papillomavirus types associated with high risk of cervical cancer.
J Clin Microbiol. 41:3221–3228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
World Health Organization: International
Statistical Classification of Diseases and Related Health Problems.
2010 Edition. World Health Organization; Geneva: 2011
|
|
27.
|
Plummer M, Schiffman M, Castle PE and
Maucort-Boulch D: A 2-year prospective study of human
papillomavirus persistence among women with a cytological diagnosis
of atypical squamous cells of undetermined significance or
low-grade squamous intraepithelial lesion. J Infect Dis.
195:1582–1589. 2007.
|
|
28.
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Rodriguez AC, Schiffman M, Herrero R,
Wacholder S, Hildesheim A, Castle PE, Solomon D and Burk R;
Proyecto Epidemiológico Guanacaste Group: Rapid clearance of human
papillomavirus and implications for clinical focus on persistent
infections. J Natl Cancer Inst. 100:513–517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Castle PE, Rodríguez AC, Burk RD, Herrero
R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon
D and Schiffman M; Proyecto Epidemiológico Guanacaste (PEG) Group:
Short term persistence of human papillomavirus and risk of cervical
precancer and cancer: population based cohort study. BMJ.
339:b25692009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Herfs M, Yamamoto Y, Laury A, Wang X,
Nucci MR, McLaughlin-Drubin ME, Münger K, Feldman S, McKeon FD,
Xian W and Crum CP: A discrete population of squamocolumnar
junction cells implicated in the pathogenesis of cervical cancer.
Proc Natl Acad Sci USA. 109:10516–10521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Tase T, Okagaki T, Clark BA, Twiggs LB,
Ostrow RS and Faras AJ: Human papillomavirus DNA in glandular
dysplasia and microglandular hyperplasia: presumed precursors of
adenocarcinoma of the uterine cervix. Obstet Gynecol. 73:1005–1008.
1989.PubMed/NCBI
|
|
33.
|
Bergström R, Sparén P and Adami HO: Trends
in cancer of the cervix uteri in Sweden following cytological
screening. Br J Cancer. 81:159–166. 1999.PubMed/NCBI
|
|
34.
|
Adegoke O, Kulasingam S and Virnig B:
Cervical cancer trends in the United States: a 35-year
population-based analysis. J Womens Health (Larchmt). 21:1031–1037.
2012.PubMed/NCBI
|
|
35.
|
Ronco G, Giorgi-Rossi P, Carozzi F,
Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando
S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R,
Schincaglia P, Zorzi M, Zappa M, Segnan N and Cuzick J; New
Technologies for Cervical Cancer screening (NTCC) Working Group:
Efficacy of human papillomavirus testing for the detection of
invasive cervical cancers and cervical intraepithelial neoplasia: a
randomised controlled trial. Lancet Oncol. 11:249–257. 2010.
View Article : Google Scholar
|
|
36.
|
Ashfag R, Gibbons D, Vela C, Saboorian MH
and Iliya F: ThinPrep Pap Test. Accuracy for glandular disease Acta
Cytol. 43:81–85. 1999. View Article : Google Scholar
|
|
37.
|
Pettersson BF, Andersson S, Hellman K and
Hellström AC: Invasive carcinoma of the uterine cervix associated
with pregnancy: 90 years of experience. Cancer. 116:2343–2349.
2010.PubMed/NCBI
|
|
38.
|
Gyllensten U, Lindell M, Gustafsson I and
Wilander E: HPV test shows low sensitivity of Pap screen in older
women. Lancet Oncol. 11:509–510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Katki HA, Kinney WK, Fetterman B, Lorey T,
Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S and Castle
PE: Cervical cancer risk for women undergoing concurrent testing
for human papillomavirus and cervical cytology: a population-based
study in routine clinical practice. Lancet Oncol. 12:663–672. 2011.
View Article : Google Scholar
|
|
40.
|
Saqi A, Gupta PK, Erroll M, Babiac A,
Blackmun D, Mansukhani M and Vazquez M: High-risk human
papillomavirus DNA testing: a marker for atypical glandular cells.
Diagn Cytopathol. 34:235–239. 2006. View
Article : Google Scholar : PubMed/NCBI
|
